| Literature DB >> 31027947 |
Zachary Fitch1, Robin Schmitz2, Jean Kwun2, Bernhard Hering3, Joren Madsen2, Stuart J Knechtle4.
Abstract
Research in transplant immunology using non-human primate (NHP) species to evaluate immunologic strategies to prevent rejection and prolong allograft survival has yielded results that have translated successfully into human organ transplant patient management. Other therapies have not proceeded to human translation due to failure in NHP testing, arguably sparing humans the futility and risk of such testing. The NHP transplant models are ethically necessary for drug development in this field and provide the closest analogue to human transplant patients available. The refinement of this resource with respect to colony MHC typing, reagent and assay development, and availability to the research community has greatly enhanced knowledge about transplant immunology and drug development.Entities:
Mesh:
Year: 2019 PMID: 31027947 PMCID: PMC6599548 DOI: 10.1016/j.trre.2019.03.002
Source DB: PubMed Journal: Transplant Rev (Orlando) ISSN: 0955-470X Impact factor: 3.943